Acetylsalicylic acid Completed Phase 3 Trials for Secondary Preventions / Stroke Prevention

IndicationsStatusPurposePhase
CompletedPrevention3
clinicaltrials.gov IdentifierTitleDrugs
NCT02239120Dabigatran Etexilate for Secondary Stroke Prevention in Patients With Embolic Stroke of Undetermined Source (RE-SPECT ESUS)
NCT00027066Warfarin Versus Aspirin Recurrent Stroke Study